Bupropion
NDC Package 67046-699-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Bupropion is a medication used to treat depression. Marketed by Coupler Enterprises Inc, this product is identified by NDC 67046-699 and is authorized under FDA application ANDA090693.

Identification & Billing

NDC Package Code
67046-699-30
Package Description
30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Product Code
67046-699
11-Digit Billing Format
67046069930
RxNorm Crosswalk
  • RxCUI: 993541 - buPROPion HCl 150 MG 24HR Extended Release Oral Tablet
  • RxCUI: 993541 - 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet
  • RxCUI: 993541 - bupropion HCl XL 150 MG 24 HR Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Bupropion XL
Dosage Form
-
Usage Information
This medication is used to treat depression. It may also be used to prevent seasonal affective disorder (SAD), a type of depression that occurs each year at the same time (for example, during winter). This medication can improve your mood and feelings of well-being. It may work by restoring the balance of certain natural substances (dopamine, norepinephrine) in the brain.

Regulatory & Marketing

Labeler Name
Coupler Enterprises Inc
FDA Application #
ANDA090693
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-14-2017
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67046-699-30 identifies a specific commercial package of 30 tablet, extended release in 1 blister pack of Bupropion XL, labeled by Coupler Enterprises Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Coupler Enterprises Inc on February 14, 2017. The current certification is valid through December 31, 2021.

What are the primary indications for this medication?

This medication is used to treat depression. It may also be used to prevent seasonal affective disorder (SAD), a type of depression that occurs each year at the same time (for example, during winter). This medication can improve your mood and feelings of well-being. It may work by restoring the balance of certain natural substances (dopamine, norepinephrine) in the brain.

How is this Coupler Enterprises Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67046069930. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67046-699-30
11-Digit CMS (5-4-2)
67046-0699-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.